院外心脏骤停后血浆和尿液肾损伤及肾功能生物标志物的预后效能
这项前瞻性观察研究纳入82例院外心脏骤停后恢复自主循环的昏迷成人患者,在0、24、72小时检测血浆NGAL、KIM-1、胱抑素C及尿NGAL、KIM-1。主要终点为出院时不良神经恢复或死亡(CPC 3-5),次要终点为AKI。45例(54.9%)达CPC 3-5,54例(65.9%)发生AKI。尿NGAL对CPC 3-5(AUC 0.79 vs 肌酐0.57)和AKI(AUC 0.81)预测最强,入院时肾生物标志物预测AKI的AUC为0.75-0.85,优于肌酐的0.65。
要点
- 82例OHCA昏迷患者中,54.9%出院时CPC 3-5,65.9%发生AKI,23.2%需肾脏替代治疗。
- 尿NGAL预测CPC 3-5的AUC为0.79,优于血清肌酐的0.57。
- 尿NGAL预测AKI的AUC为0.81;入院时肾生物标志物预测AKI的AUC为0.75-0.85,优于肌酐的0.65。
- 血清肌酐升高>20%和/或需透析者CPC 3-5发生率为71%,而肌酐下降>20%或稳定者为20%(p<0.001)。
适用人群与场景
- 纳入:院外心脏骤停后恢复自主循环的昏迷成人患者,共82例,中位年龄59.5岁,89.0%为男性。
研究设计与关键结果
- 研究类型:前瞻性观察研究;样本量82例;人群为院外心脏骤停后恢复自主循环的昏迷成人。
- 主要终点:出院时不良神经恢复或死亡(CPC 3-5)共45例(54.9%),其中死亡39例(CPC 5),不良神经恢复6例(CPC 3-4)。
- 次要终点:AKI发生54例(65.9%),其中19例(23.2%)需肾脏替代治疗。
- 血清肌酐升高>20%(n=33)和/或需透析者CPC 3-5发生率为71%,而肌酐下降>20%(n=23)或稳定(n=7)者为20%(p<0.001)。
- 尿NGAL预测CPC 3-5的AUC为0.79,血清肌酐AUC为0.57;尿NGAL预测AKI的AUC为0.81。
- 入院时肾生物标志物预测AKI的AUC为0.75-0.85,血清肌酐AUC为0.65。
证据类型、等级与局限
- 证据类型:前瞻性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,肾特异性生物标志物在OHCA后早期AKI检测和患者中心结局预测方面优于血清肌酐。
- 作者认为,早期生物标志物测量可能改善基于传统血清肌酐评估的AKI和结局风险分层。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: Acute kidney injury (AKI) after out-of-hospital cardiac arrest (OHCA) portends worse outcomes, yet serum creatinine (sCr) underestimates injury. We evaluated whether kidney injury biomarkers improve early prediction of patient-centered outcomes and AKI after OHCA compared with sCr.
METHODS: In this prospective observational study, we measured plasma neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1) and cystatin C, and urinary NGAL and KIM-1 at 0, 24 and 72 h post-return of spontaneous circulation in comatose adult OHCA patients. The primary outcome was poor neurological recovery or mortality (Cerebral Performance Category (CPC) 3-5) at hospital discharge; secondary outcome was AKI. We compared biomarker distributions and discriminatory performance from areas under receiver operating characteristic curves (AUC).
RESULTS: Among 82 patients (median age 59.5 years, 89.0% males), 45 (54.9%) had CPC 3-5 (39 died, CPC 5; 6 poor neurological recovery, CPC 3-4). AKI occurred in 54 (65.9%) patients, of whom 19 (23.2%) required renal replacement therapy. Patients in whom sCr rose by >20% (n = 33) and/or required dialysis had elevated biomarkers and a 71% CPC 3-5 incidence, versus 20% in those with decreasing by >20% (n = 23) or stable sCr (n = 7) (p < 0.001). Urinary NGAL was the strongest predictor for both CPC 3-5 (AUC 0.79 vs sCr 0.57) and AKI (AUC 0.81). Admission kidney biomarkers predicted AKI (AUCs 0.75-0.85) better than sCr (AUC 0.65).
CONCLUSION: Kidney-specific biomarkers were superior to sCr for early AKI detection and prediction of patient-centered outcomes after OHCA. Early biomarker measurement may improve AKI and outcome risk stratification beyond conventional sCr-based assessment.
参考来源
- Lim SL, Woo KL, Au AYM, et al. Prognostic performance of plasma and urinary biomarkers of kidney injury and function after out-of-hospital cardiac arrest. Resuscitation. 2026. PMID: 42264173. doi:10.1016/j.resuscitation.2026.111163
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。